Publications
102
Citations
5,001
Est. group size
—
Recurring co-author estimate
Active years
33
Publishing since 1994
J. Stephen Jenkins's publication record centers on interventional cardiology and vascular medicine, with particular focus on treatments for hypertension (high blood pressure), coronary artery disease, and peripheral artery disease. Much of the recent work involves ultrasound renal denervation, a catheter-based procedure that disrupts nerves near the kidneys to help lower blood pressure, tested through large clinical trials. Additional work explores atherosclerosis (artery plaque buildup) in animal models and devices used in structural heart procedures.
Publication output has fluctuated over the last decade without a clear steady increase or decrease, with a peak around 2019 and 2023 and a modest average of about 4 papers per year in the most recent five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Lighting the Way Forward?
JACC: Cardiovascular Interventions · 2026
- Ultrasound Renal Denervation Attenuates Early Cardiac Remodeling After Acute Myocardial Infarction in a Swine Model of Hypertensions and Dyslipidemia: A Pilot Study
Clinical and Translational Science · 2025
- Facilities Management Integration into Construction Management Curriculum: Core Competencies
CIB Conferences · 2025
- TCT-588 24-Month Durability of the Blood Pressure Lowering Effect of Ultrasound Renal Denervation for Hypertension with the Paradise System
Journal of the American College of Cardiology · 2025
- Abstract 4364300: The Senolytic Navitoclax (ABT263) Reduces Coronary Atherosclerosis and Upregulates Plaque Stability in Atherosclerotic Pigs
Circulation · 2025
- Vascular Access
2024
- TCT-46 Ultrasound Renal Denervation Protects the Ischemic-Reperfused Myocardium in a Swine Model of Hypertension and Dyslipidemia
Journal of the American College of Cardiology · 2024
- Endovascular Ultrasound Renal Denervation to Treat Hypertension
JAMA · 2023
- Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
JAMA Cardiology · 2023
- Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program
Circulation · 2023
- Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia
JCI Insight · 2023
- Systematic review of multiple versus single device closure of Secundum atrial septal defects in adults
Cardiovascular revascularization medicine · 2023
- TCT-398 Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: 6-Month Results Following Blinded Medication Titration in the Randomized, Sham-Controlled RADIANCE II Pivotal Trial
Journal of the American College of Cardiology · 2023
- OSHA-Investigated Electrocution Fatalities in the Construction Industry, 2015-2019
EPiC series in built environment · 2023
- Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation
JAMA Cardiology · 2022
- Journal of the American College of Cardiology×10
- Progress in Cardiovascular Diseases×4
- Circulation×4
- Cardiovascular revascularization medicine×4
- JACC: Cardiovascular Interventions×3
- Raghu L. Motaganahalli
Medicine · Indiana University
- Mackenzie Madison
Medicine · Indiana University
- Joshua Weinberg
Medicine · The Ohio State University
- Peng Wang
Medicine · The Ohio State University
- Corey A. Kalbaugh
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile